People · Operator
Named in public records as an officer, director or promoter · active 2017–2017 · Biotech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Phylos Bioscience, Inc. | — | Biotech | Series B | $23.9M | $2.2M | 2017 |
Stephen J Lile at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Stephen J Lile on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Dan Reiner | 1 | 2 |
| David J Patterson | 1 | 2 |
| Mina J Mishrikey | 1 | 2 |
| Mina Mishrikey | 1 | 2 |
| Timothy J Gregory | 1 | 1 |
| Scott J Bowman | 1 | 1 |
| Lada J Rasochova, PhD | 1 | 1 |
| Mowgli Holmes | 1 | 1 |
| David A Patterson | 1 | 1 |
| Ralph A Risch | 1 | 1 |
| Barbara A Peachey | 1 | 1 |
| Dylan J Anderson | 1 | 1 |
| Nishan Karassik | 1 | 1 |
| Barbara J Peachey | 1 | 1 |
| Ralph J Risch | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.